Thrilled to announce that Dr. Phuoc Tran will be joining ⁦MD Anderson Cancer Center⁩ as Chair of GU Rad Onc Dept. Can’t wait to see all that you will do to help us #endcancer

Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer - Amar Kishan UCLA Jonsson Comprehensive Cancer Center oncodaily.com/science/amar-u… #Cancer #Oncology #OncoDaily #Health #Medicine #MedEd #MedX #MedNews

May 29, 2025 ➡️ Part 2 of our Indigenous Oncology Webinar in partnership with CARO-ACRO Part 1 was very well received, and we are thrilled to welcome Dr. Cassandra Felske-Durksen to discuss "Reconciliation." Stay tuned for a sign up link!

🔬Unite with fellow conquerors around the world celebrating milestone events and honoring loved ones by funding breakthrough cancer research. p2p.conquer.org/uniteandconque…

Kekoa Taparra, MD, PhD, MPH's cancer research is driven by his dedication to the people of Hawaii. Conquer Cancer funding empowers him to pursue better care. Learn more: brnw.ch/21wSubB #CancerResearch #Hawaii

Recent NIH grant terminations have resulted in deep uncertainty among researchers🧑‍🔬& academic institutions🏫. In JAMA, we characterize the scope of terminations, types of grants affected, and differential impact of cuts across career stages Link: jamanetwork.com/journals/jama/…

The #radonc oral boards results are in: 7️⃣7️⃣% of first time test takers passed - the lowest ⬇️ it’s been in since 2016 Wonder what was different this year 🤔

Interesting. Hyunsoo Joshua No, MD, CMD and I will be dropping a new At The Beam Podcast episode soon to share our experience. Overall, we found the exam to be very fair. Perhaps like most things in life, we ebb and flow

Postoperative stereotactic body radiotherapy for prostate cancer was well-tolerated with similar urinary and bowel patient-reported outcomes over two years vs conventional radiotherapy. ja.ma/43dhkXR Amar Kishan

A new study led by Amar Kishan & published in JAMA Oncology shows that post-surgery radiation for prostate cancer can be safely completed in just 5 sessions using SBRT instead of daily sessions for several weeks, with no added side effects. bit.ly/4mkokLq

UCLA Radiation Oncology's Matthew J. Farrell has been named the inaugural Hope Fellow of the newly established Institute for the Study of Hope, Dignity and Wellbeing. Read more here: uclahealth.org/news/release/u…

Congratulations to UCLA Health radiation oncologist Matthew J. Farrell on being named the inaugural Hope Fellow of the new Institute for the Study of Hope, Dignity and Wellbeing, a global effort to advance patient-centered care through the science of hope. bit.ly/3SHx54y

Caring for patients with cholangiocarcinoma is deeply personal. Thank you Cholangiocarcinoma Foundation for sharing my story! UCLA Health cholangiocarcinoma.org/qa-with-dr-tru…

🎉 Congrats to Dr. Agnes Ewongwo, MD MPH who received the Stanford Medicine GME Well Being Award! Awarded up top at the 2025 Teaching Excellent Awards, alongside the BEST educators throughout all of Stanford Health Care! Well deserved!🏆 Stanford Radiation Oncology

UCLA Launched ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT - Amar Kishan Amar Kishan UCLA Jonsson Comprehensive Cancer Center IJROBP - The Red Journal oncodaily.com/insight/illusi… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedEd #MedNews

🎓✨ Congratulations to our graduating Radiation Oncology seniors! 🎓✨ It has been an incredible honor to train alongside you-your dedication to patient care, passion for advancing our field, and unwavering support for your colleagues have left an indelible mark on all of us.

Asian Americans are one of the most heterogenous US racial/ethnic groups more than doubling in population since 2000. For one, #AsianAmericans speak over 100 different languages & dialects w/ many less proficient in English & further disparities b/n immigrants & US born. 3/x

Viewpoint: Prostate cancer screening is shifting toward a more beneficial and less harmful approach by using MRI-targeted strategies, which reduce unnecessary biopsies and overdiagnosis. ja.ma/45rVOSb Ivo Schoots

Exciting news for the oncology community! 🎉We're thrilled to launch the official X page for JCO Oncology Advances! Follow us for the latest high-quality, open-access early phase and trial-adjacent research. Let's advance cancer care together.

🎓 Grateful for all the friends and ʻohana who got me through residency. I’ll miss these people so much. But looking forward to new adventures in Los Angeles. 👏🏼Congrats to all the graduating residents and good luck to all the PGY1s and PGY2 rad oncs!